Ellagic Acid Effect on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors, usually with a common pathophysiological origin in insulin resistance and abdominal obesity. Considering the reported effects of ellagic acid (EA) on insulin resistance and abdominal obesity, the aim of this study was to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidalgo-Lozada, Gladys Maribel, Villarruel-López, Angélica, Martínez-Abundis, Esperanza, Vázquez-Paulino, Olga, González-Ortiz, Manuel, Pérez-Rubio, Karina Griselda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572658/
https://www.ncbi.nlm.nih.gov/pubmed/36233611
http://dx.doi.org/10.3390/jcm11195741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572658/
https://www.ncbi.nlm.nih.gov/pubmed/36233611
http://dx.doi.org/10.3390/jcm11195741

Ejemplares similares